Tenax Therapeutics, Inc. (TENX) key performance indicators and operating metrics (2 metrics) from SEC EDGAR filings, earnings calls, and investor decks. First-party data.
| Metric | Latest Value | Period |
|---|---|---|
| Patients Expected to Be Enrolled in Phase 3 LEVEL Study | 230.00 | FY2025-Q3 |
| Gross Proceeds Raised in Private Placement | 25M | FY2025-Q1 |
Back to TENX overview · TENX earnings · TENX holders
Data sourced from U.S. SEC EDGAR filings, earnings call transcripts, and investor decks. Not personalized investment advice.